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Background: Many patients receive treatment for chronic pain from a primary care provider.  
There is a known relationship between sleep and pain perception, making sleep an important 
factor to assess in patients with chronic pain.  Unlike in specialist pain management settings, 
sleep is not routinely assessed in the primary care setting, resulting in missed treatment 
opportunities and suboptimal chronic pain management.  Objective: To assess the sleep quality 
of patients with chronic pain in the primary care setting through the use of the Pittsburgh Sleep 
Quality Index (PSQI) questionnaire during the patient intake process.  Methods: Patients 
meeting inclusion criteria received a PSQI while waiting to see a provider at chronic care visits.  
The primary care provider was alerted to the result, and patients who were identified as having 
poor sleep quality scoring > 5 on the PSQI had the opportunity to receive further assessment and 
treatment from the provider.  Results: Sample data scores revealed 77.7% (n = 7) of patients 
with chronic pain had global PSQI greater than 5, which is indicative of impaired sleep quality 
(M = 13, SD = 5.24).  All patients (n = 9) received educational handouts from their providers 
concerning sleep hygiene.  The number of patients with an insomnia diagnosis (n = 7) and the 
number of patients receiving prescribed medication for insomnia (n = 2) did not change after the 
screening implementation.  Conclusion: Implementation of a sleep assessment tool such as the 
PSQI did not support the increased identification of an insomnia diagnosis or increased 
management of insomnia with medication in the primary care setting. 
 
Keywords: Sleep quality, sleep assessment, chronic pain  
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Title of Project 
The title of this project is Sleep Quality Screening in Primary Care Patients with Chronic Pain. 
Background 
Chronic pain and sleep have an intricate, bidirectional relationship with pain decreasing 
the quality of sleep, and poor sleep quality being known to exacerbate pain (Abbasi, Kazemifar, 
Fatorechi, & Yazdi, 2018).  According to the 2016 National Health Interview Survey, greater 
than 50 million adults in the United States suffer from chronic pain (Dahlhamer et al., 2018).  
Among people with sleep difficulties who suffer from chronic pain, more than four out of ten 
stated that poor sleep quality interfered with their work (Appold, 2015).  At the individual level, 
poor sleep quality adversely affects activity performance, mood, pain experience, and overall 
quality of life.  Patients with insomnia reported experiencing spontaneous pain on twice as many 
days as healthy controls during at-home actigraphy recording (Haack et al., 2012).  Management 
of patients with chronic pain is challenging and time-consuming.  Over 90% of prescribers stated 
that assessing medical comorbidities such as sleep was extremely important in this population 
however, 66% admitted being unable to refer to guidelines for therapy (Provenzano, Kamal, & 
Giannetti, 2018). 
Problem Statement 
Primary care providers (PCP) are regularly responsible for treating and managing chronic 
pain in adults, but without the specialized knowledge of those practicing in the pain management 
discipline (Provenzano et al., 2018).  For patients with chronic pain managed at the primary care 
level, sleep assessments are not routinely integrated into primary care visits.  The question this 
project seeks to answer is, in adults ages 18 and older diagnosed with chronic pain who present 
to primary care offices for chronic care visits, does routine screening for sleep quality with the 
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Pittsburgh Sleep Quality Index (PSQI) increase the identification of a diagnosis of insomnia and 
management with medication in a single sample of patients after screening was implemented as 
compared to before screening was implemented? 
Needs Assessment 
In the past, practitioners were encouraged to treat pain and sleep as unidirectional, with 
the notion that decreased pain would improve sleep quality.  Finan, Goodin, and Smith (2013) 
have suggested a multidirectional relationship between sleep and pain such that impaired sleep 
heightens a patient’s pain perception leading to a cyclical effect of fatigue and pain.  
Recognizing and treating sleep has been shown to improve the quality of sleep and improve pain 
severity in patients with chronic pain (Finan et al., 2013). 
The quality improvement project site is a Federally Qualified Health Center (FQHC), 
which provides care to a rural 1,017 square mile area bordering Maryland in south-central 
Pennsylvania.  During the 60-day implementation period, both offices combined conducted 
approximately 3,000 patient visits for a variety of primary care needs.  The project site serves 
patients with chronic pain.  Best practices for pain management in this population are important, 
as public programs absorb financial repercussions of excessive visits and a greater need for 
medications through the use of 340b pharmacy programs, Medicare, and Medicaid (Chang, 
Bynum, & Lurie, 2019).  The project site is well-suited for the implementation of this quality 
improvement project as there are few primary care providers in the area, and the nearest specialty 
pain management practice is located 45 minutes away.  Other strengths include the use of a 
robust electronic medical records system that facilitates easy review by the doctor of nursing 
practice (DNP) student of documentation as well as an internal culture among providers of 
employing multimodal pain relief for chronic pain management.   
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The project site’s existing internal structure supports the integration of sleep assessments 
to be easily integrated into chronic care visits for patients with chronic pain.  There are already 
policies and procedures in place for the management of chronic pain, such as routine urine drug 
screening and random medication counts performed by the nursing staff for those taking opioid 
medication.  The practice does not routinely assess patients with chronic pain for sleep quality 
and chronic pain is not always well managed.  A meta-analysis by Mathias, Cant, and Burke 
(2018) suggested that the prevalence of poor sleep quality in patients with chronic pain is 72%; 
however, few patients with chronic pain at the project site had documentation addressing sleep 
quality in the medical record.  A weakness of the project site is the risk for variability between 
the two office locations for data collection.  With multiple offices comprised of different 
providers and support staff, the potential exists for the sleep assessment to be conducted 
inconsistently between the two offices.  See Appendix A for a complete SWOT analysis. 
Aims, Objectives, Purpose Statement 
The aim of this project was to improve the identification of a diagnosis of insomnia and 
management of insomnia with medication among patients with a history of chronic pain in the 
primary care setting through the use of a validated self-assessment sleep questionnaire.  In 
support of this aim, three objectives were created: (a) at least 75% of patients with a history of 
chronic pain who present for a chronic care visit will be screened for sleep quality within a 2-
month time period using the PSQI; (b) during this 2-month screening period, all patients with 
newly demonstrated poor sleep quality based on positive results from the PSQI will have his/her 
provider for that visit alerted to this finding; and (c) providers alerted to a patient with a positive 
PSQI will provide an intervention to a minimum of 90% of patients identified during the 2-
month investigation.  The purpose of this quality improvement project was to introduce a 
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standardized sleep assessment tool into the primary care setting to screen patients with chronic 
pain for the presence of untreated poor sleep quality. 
Review of Literature 
A search of the literature from CINAHL, PsycINFO, and PubMed was performed in May 
2019 to March 2020 for articles containing the keywords sleep quality, quality of sleep, or sleep 
problem and pain management, pain relief, pain control, or pain reduction.  The MeSH search 
terms sleep and pain management were used to search the PubMed database.  After removing 
duplicates and screening articles published in English, 23 relevant articles were reviewed (see 
Appendix B), and the Johns Hopkins Evidence-Based Model was used to appraise the literature 
(Dang & Dearholt, 2018).  The available evidence was primarily level III of A or B quality 
consisting of two systematic reviews, a meta-analysis, a review of literature, a randomized 
controlled trial, several quasi-experimental studies, and numerous descriptive studies on pain and 
sleep. 
Sleep disorders encompass a broad range of impairment related to a patient’s ability to 
achieve the necessary sleep required to function effectively (Schutte-Rodin, Broch, Buysse, 
Dorsey, & Sateia, 2008).  Insomnia, the most common sleep disorder, is defined as trouble 
initiating or maintaining sleep, which is associated with negative daytime consequences and is 
not attributable to environmental circumstances, including a lack of opportunity to sleep (Sateia, 
2014).  Another important component of sleep as it relates to pain is sleep latency, the time it 
takes to fall asleep following bedtime (Sateia, Buysse, Krystal, Neubauer, & Heald, 2017). 
Patients with chronic pain are at greater risk for poor sleep quality due to taking opioids, 
which have the potential to alter sleep regulation and are independently associated with poor 
sleep quality and insomnia (Els et al., 2017).  Of the multiple dimensions to sleep quality, sleep 
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latency and restlessness may have a stronger relation to pain perception than total sleep duration 
(Song et al., 2018).  Sleep duration and latency are associated with decreased pain thresholds 
(Edwards, Almeida, Klick, Haythornthwaite, & Smith, 2008; Haack et al., 2012; Mathias, Cant, 
& Burke, 2018).  Improvements in fatigue and sleep were significantly associated with the 
reduction of pain intensity (Vega et al., 2019).  Improvements have occurred in sleep latency 
following a single brief educational intervention focusing on strategies to improve sleep hygiene 
(Berry et al., 2015; Vega et al., 2019). 
The American Academy of Sleep Medicine (AASM) recommends the assessment of 
patients with symptoms of insomnia and recommends treatment when insomnia has “a 
significant negative impact on the patient’s sleep quality, health, comorbid conditions, or 
daytime function” (Schutte-Rodin et al., 2008, p. 487).  In the outpatient setting, assessment is 
most practically accomplished through the use of self-reported questionnaires that screen for 
sleep disorders, the oldest and most studied questionnaire being the PSQI (Klingman, Jungquist, 
& Perlis, 2017).  The PSQI provides a meaningful breakdown of a patient’s sleep quality into 
multiple dimensions of sleep, which provides an advantage over other well-established sleep 
assessment instruments that only provide a single summation of a patient’s responses (Klingman 
et al., 2017).  See Appendix C for a comprehensive review of literature evidence matrix. 
Theoretical Model 
The theory of unpleasant symptoms (see Appendix D) seeks to explain how a physiologic 
pathology can trigger a psychological response that in turn can heighten the perception of the 
initial symptom, in addition to creating a new independent symptom (Lenz, Pugh, Milligan, Gift, 
& Suppe, 1997).  It explains symptom clusters in terms of three factors: the actual symptoms, 
factors that influence the symptoms, and the performance outcomes for the patient (Lenz et al., 
 
SLEEP QUALITY SCREENING AND CHRONIC PAIN 
  
10 
1997).  Consequently, pain and sleep may not be unidimensional symptoms in the chronic pain 
population, and the assessment and treatment need to be comprehensive to treat both conditions 
effectively. 
Translation Model 
The Ottawa Model of Research Use (see Appendix E) was selected to guide the 
translation of evidence.  It describes the overall translation process beginning with assessing 
barriers and supports, monitoring the adoption process of the intervention, and assessing the 
results of the project (Graham & Logan, 2004).  The useful aspect of this model is the inclusion 
of supportive steps in the process map, such as analyzing the attributes of the innovation, the 
attitudes of adopters of the intervention, and the response of the practice environment.  Specific 
to this project, the DNP student gave careful attention to the ongoing monitoring of the 
implementation as it was influenced by uncontrolled events and perceived barriers as reported by 
staff.  As part of the continuous process evaluation, it was important to acknowledge how these 
factors informed the outcomes of the implementation and use this insight when evaluating the 
outcomes of the project, such as a smaller than expected sample size.  The model was 
particularly useful in the context of adapting the implementation during the 2019 novel 
coronavirus pandemic, which led to remote oversight of the implementation rather than the 
intended direct on-site supervision originally planned. 
Methodology 
The quality improvement project involved a single sample of primary care patients with a 
history of documented chronic pain as determined by a retrospective chart review.  Patients who 
presented for chronic care visits with a history of chronic pain as determined by a documented 
international classification of diseases (ICD-10) code indicating chronic pain were identified by 
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the nursing support staff when escorting patients to an exam room.  Eligibility was not dependent 
on current opioid usage.  Patients who met the inclusion criteria were provided informed consent 
(Appendix F) and a PSQI questionnaire to complete while waiting to see the provider before the 
appointment in a private exam room. 
Participants 
The patients of the healthcare center with a history of chronic pain must have been 18 
years of age or older and could read and write in English to participate in this project.  Exclusion 
criteria included being actively seen by a pain management specialist and being unable to 
provide informed legal consent.  On average, 30 patients per month are treated for chronic pain 
by each PCP in western Pennsylvania, therefore 60 patients were projected to be included in this 
project assuming a 50% participation rate of the patients seeing each of the four full-time 
providers (Provenzano et al., 2018). 
Setting 
The setting for this project was a small two-location, rural FQHC.  The facility avoids the 
use of controlled substances to treat pain whenever possible.  The office consists of multiple 
providers.  On any given day, there are two providers with their own medical assistants at each 
site.  A medical assistant or licensed practical nurse facilitates patient intake.  The main office 
location consists of eight exam rooms and a procedure room.  There is ample space in a large 
shared provider office for providers, students, and the project leader.  The second office location 
offers similar accommodations. 
Tools 
 The PSQI (see Appendix G) was chosen as a standardized instrument to measure the 
quality of patient sleep (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989).  A self-reporting 
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sleep questionnaire requiring less than 10 minutes to complete, the PSQI measures sleep across 
seven domains: (a) subjective sleep quality; (b) sleep latency; (c) sleep duration; (d) habitual 
sleep efficiency; (e) sleep disturbances; (f) use of sleep medication; and (g) daytime dysfunction 
in the month preceding the time of assessment (Buysse et al., 1989).  Each sleep domain is 
scored 0-3, and a global sleep quality score out of a possible total of 21 is calculated as the sum 
of the seven dimensions of the assessment tool (Mollayeva et al., 2016).  Global PSQI values 
greater than five are indicative of poor sleep quality.  This tool has demonstrated reliability 
(Cronbach’s α = 0.83), and construct validity has been supported through the use of the PSQI in 
subjects with varying known sleep disorders consistently yielding p < 0.001 (Buysse et al., 
1989).  Written permission (see Appendix H) to use the PSQI in this project was granted by Dr. 
Daniel Buysse and The University of Pittsburgh in July 2019. 
Intervention  
The nursing support staff identified the patient as having chronic pain by reviewing 
patient charts for ICD coding supporting a chronic pain diagnosis.  Patients who met the 
inclusion criteria were provided the opportunity to complete the PSQI during the check-in 
process.  Nursing support staff scored the PSQI and alerted the provider if poor sleep quality was 
indicated by scores greater than five before the patient saw the provider.  After reviewing the 
results of the PSQI, the provider was encouraged to make appropriate evidence-based 
recommendations unless otherwise indicated, which included assigning a formal diagnosis of 
insomnia, the distribution of printed educational material concerning sleep hygiene (see 
Appendix I), or medication management.  Providers were free to use their knowledge of the 
patient and professional discretion when pursuing evidence-based interventions with the patient; 
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however, only interventions categorized into areas of diagnosis, patient education, or medication 
management were considered for the scope of this project. 
The DNP student serving as the project leader assisted the support staff and providers 
with questions and logistic concerns.  Before the implementation of the project, several meetings 
were held with staff from both offices.  Evidence in the literature was shared indicating the role 
of sleep in patients with chronic pain.  Data were reviewed with staff highlighting the high 
prevalence of poor sleep quality in the local region.  The PSQI was discussed, samples 
distributed, and scoring reviewed. 
Each provider received a binder detailing the interpretation of the PSQI scoring for each 
dimension of sleep.  A systematic review published by the AASM about treatment practices and 
recommendations was provided in addition to highlighted national and statewide prevalence data 
for sleep disorders and data on frequently occurring comorbid conditions found within the 
population by the Centers for Disease Control and Prevention (CDC).  Recommendations from 
the CDC for identifying and treating common sleep disorders such as insomnia, REM sleep 
behavior disorder, shift work sleep disorder, and an introduction to brief behavioral treatment for 
insomnia (BBTI) were given to the providers.  Intervention fidelity was planned to occur as part 
of a weekly review of patients seen to audit for missed opportunities for screening, lack of 
communication of the results to the provider, and the frequency in which the providers took 
action based on the results from the PSQI.  See Appendix J for a process map. 
Data Collection 
Data collection was comprised of an analysis of completed PSQI forms and retrospective 
reviews of the electronic medical record.  The post-implementation phase included data 
extraction for use in descriptive statistics and univariate analysis.  Data analyzed included the 
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total number of (a) patients who completed the PSQI, (b) patients who screened positive for poor 
sleep per the PSQI, (c) breakdown of sleep dimension scores on the PSQI, and (d) patients who 
received follow-up from their provider related to the PSQI results.  Demographic data were also 
collected including age, gender, past medical history of a sleep disorder, history of sleep disorder 
treatment with medication, and comorbid conditions. 
Cost Analysis 
 A comprehensive budget (see Appendix K) listed donated expenses for consideration of 
the costs of labor involved for use in future implementations.  The project’s total estimated cost 
was $9,180.00, all of which was donated on behalf of the facility or the DNP student.  The 
relative costs are offset by reducing visits and healthcare utilization.  Insurance programs save 
money as a result of fewer claims, patients save money with fewer expenses for those with cost-
sharing insurance plans, and the facility receives financial incentives tied to improved outcomes.  
In addition to reducing acute visits to the PCP, a reduction of hospitalizations and emergency 
department visits result in fewer follow-up appointments and aid in long-term sustainability from 
a cost perspective. 
Timeline 
A GANTT chart (see Appendix L) was created to guide the timeline for this project.  Pre-
implementation tasks include the project proposal, implementation site board approval, 
Institutional Review Board (IRB) approval, and preparation of materials for the implementation 
phase.  Pre-implementation was completed in February 2020.  The implementation phase 
included meetings with staff in addition to the implementation of the PSQI in March 2020.  The 
implementation continued through May 2020, at which point the post-implementation phase 
began with data extraction, statistical analyses, presentation of the results to the facility, and the 
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creation and submission of the final manuscript.  The post-implementation phase concluded in 
July 2020. 
Ethics and Human Subject Protection 
 Formal support was obtained from the Hyndman Area Health Center leadership, and final 
research protocol approval was deferred to the IRB at Messiah University.  Approval from the 
Messiah University IRB was obtained prior to initiating the quality improvement project.  All 
participants were protected by the Health Insurance Portability and Accountability Act of 1996 
(HIPAA), which provides privacy protections for the patients’ health information (Modifications 
to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules, 2013).  
Additionally, the DNP student and practice staff who conducted this project carefully followed 
the established guidelines and regulations to ensure all protections were afforded to patients in 
the primary care office.  All information collected as part of evaluating the impact of this project 
were aggregate data from the project participants and did not include any patient identifiers. 
The risks to patients participating in this project were no different from the risks of 
patients who did not complete the PSQI survey instrument, which is the current standard of care.  
Participant confidentiality was assured by coding the participants using individual identification 
numbers.  The list of participants was kept secured in double-locked, tamper-proof containers at 
each practice location, only accessible to the DNP student.  Electronic files were password-










Analysis and Evaluation  
Quantitative data analysis was performed using IBM SPSS version 26.0.  Descriptive 
statistics were reviewed for patient demographics, including age, gender, past medical history, 
global PSQI scores, as well as the seven individual dimensions of sleep quality measured by the 
PSQI.  To evaluate the differences between demographics and the results of the PSQI, chi-square 
and Fisher’s exact test of independence were conducted.  Because the outcome data consisted of 
paired samples, a McNemar’s test was used to ascertain whether a significant change had 
occurred in insomnia diagnosis or treatment with medications before the sleep assessment was 
conducted (as determined through historical chart review) as compared to after the patient 
completed the sleep assessment and met with the provider. 
Nine patients were included in this quality improvement project aged 42-90 (M = 57.11, 
SD = 14.28), the majority of which were female (55.6%, n = 5).  As indicated by ICD coding, 
77.8% (n = 7) of patients had a documented history of a sleep disorder in the medical record.  
The sample population had a significant number of comorbidities with the most common being 
obesity (88.9%, n = 8), coronary heart disease (66.7%, n = 6), and depression (55.6%, n = 5).  
See Appendix M for a complete listing of highlighted comorbidities within the sample.  An 
analysis of individual participant demographic variables found that female participants were 
significantly more likely to report taking sleep medication three or more times a week on the 
PSQI as compared to male participants (χ2 (1) = 5.760, p = .048, Fisher’s exact test).  There were 
no other statistically significant relationships found between the demographic variables of age, 
gender, or past medical history and the results of the PSQI. 
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An analysis of the sample data scores revealed 77.7% (n = 7) of patients with chronic 
pain had global PSQI greater than five, which is indicative of impaired sleep quality (M = 13, SD 
= 5.24).  See Appendix N for a detailed description of the PSQI score results by sleep dimension.  
All patients (n = 9) received educational handouts from their providers concerning sleep hygiene.  
The number of patients with an insomnia diagnosis (n = 7) and the number of patients receiving 
prescribed medication for insomnia (n = 2) did not change after the screening was implemented.  
The McNemar’s test determined that there was not a statistically significant difference in the 
identification of a diagnosis of insomnia or the management of insomnia with medications before 
and after the screening was implemented, p = 1.00. 
Discussion 
The data highlight the significant prevalence of poor sleep quality in this sample of 
patients with chronic pain.  The high occurrence of poor sleep quality among patients with 
chronic pain in this sample is consistent with previously published literature, which found that 
patients with chronic pain are more than twice as likely to have poor sleep quality as compared 
to healthy patients (Call-Schmidt & Richardson, 2003).  Of the 77.8% of patients with a 
documented diagnosis of poor sleep quality, only two patients had documentation in the medical 
record of treatment with medication.  No new medication regimens were initiated as a result of 
this intervention.  While all patients in the sample population (n = 9) received printed educational 
materials about sleep hygiene, no new diagnoses of insomnia were noted in the medical record 
following the implementation of the sleep quality assessment.  In short, the implementation of 
the PSQI did not increase the identification of a diagnosis of insomnia or increase the 
management of insomnia with medication in this sample.  This highlights that assessment alone, 
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even with well-designed tools such as the PSQI, does not yield statistically or clinically 
significant outcomes. 
In the context of the pre-intervention objectives, the aims of this project were only 
partially met.  All patient results (positive or negative) from the PSQI were communicated to the 
provider.  While all patients in the sample received educational materials exceeding the 90% or 
greater original objective, there was no effect on the identification or management with 
medication.  Chronic care visits conducted using telehealth systems resulted in a decreased 
number of eligible patients available to participate in this project in relation to the total number 
of documented chronic care visits during the implementation period.  Strategies to sustain the 
project going forward include discussing with providers ways to offer the PSQI to patients 
virtually in the case of future social distancing and stay-at-home orders impacting the ability of 
patients to safely present to the office in person.  Barriers experienced by the providers that may 
have prevented the application of the PSQI results to identification and management of poor 
sleep quality must also be explored prior to continued use. 
Sleep assessments such as the PSQI are not frequently a part of chronic care visits in 
many primary care offices.  Barriers to implementation and interpretation of the assessment 
results include time constraints not present in specialty offices such as decreased appointment 
times and providers needing to actively managing multiple comorbidities in addition to chronic 
pain.  Primary care providers also have fewer specialized resources and education to prepare 
them to provide evidence-based recommendations and treatment modalities.  Any of these 
barriers alone may account for the effect size of zero for the implementation of the PSQI in this 
setting.  Future research may discover other barriers to identifying insomnia and managing 
symptoms with medication that are unique to the rural primary care setting. 
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An unexpected finding from the review of completed PSQI was the report of 44.4% (n = 
4) of patients taking medications for sleep three or more times each week despite only 22.2% (n 
= 2) patients having documented medications indicated for sleep in the medical record.  This 
knowledge should prompt providers to clarify what medications (over the counter or 
prescription) the patient may be taking for insomnia.  From a safety perspective, patients may be 
taking medications that are contraindicated or taking medication inappropriately for sleep that 
has been prescribed for another purpose altogether.  It is important to note that all four patients 
who indicated they took medication for sleep three or more times a week were female.  This 
complements the statistically significant relationship found between the use of sleep medication 
and gender, the only demographic variable that showed a statistically significant relationship 
with results from the PSQI. 
There are limitations to this project.  COVID-19 played a significant role in the execution 
of the implementation of sleep quality assessments.  Statewide restrictions of non-essential travel 
and business prevented many patients from attending chronic care appointments.  Of those 
patients with chronic pain who did need to have chronic care appointments, telephone and virtual 
appointments were conducted for some in light of social distancing recommendations.  These 
patient appointments did not follow the usual intake process and resulted in a missed opportunity 
for assessment with the PSQI.  The project’s small sample size is underpowered thus increasing 
the risk of a Type II error; nonsignificant findings must be viewed with caution.  The findings 
may not accurately capture a true representation of the rural primary care practice’s population of 
patients with chronic pain.  Another limitation in the implementation of this project is the 
homogenous racial and ethnic makeup of the patient population.  The local population is 
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predominately lower to middle-class Caucasians of European descent, which may reduce 
generalizability to other more diverse populations of patients with chronic pain. 
For future research, an investigation into patient reports of using unreported medication 
for sleep-related purposes may provide insight into the lack of documentation in the medical 
record of sleep medication despite patients with chronic pain citing frequent use according to the 
PSQI in this sample.  In addition, a nonequivalent groups pre-post study design to ascertain the 
impact of including the PSQI assessment tool into care would provide valuable insight into 
eliminating any potential confounding variables.  As a future a priori analysis, control and 
intervention groups of 237 participants each would provide an adequate sample size when 
considering a projected 10% loss of participation rate given 80% power, an alpha of .05, and a 
small to medium effect size.  Although this may present practical difficulties in recruiting a large 
number of participants with chronic pain in a rural primary care setting, future research is needed 
to demonstrate clinical significance and provide high-level evidence to support using a 
standardized sleep assessment tool such as the PSQI in this population. 
Conclusion 
  Sleep and pain are interrelated.  For patients with chronic pain, optimizing sleep quality 
is the responsibility of many primary care providers managing this population of patients not 
only to improve sleep quality, but also to complement pain management.  As a standard of 
practice, sleep is not routinely assessed at chronic care visits in the primary care setting.  Data 
from this project suggest that implementation of a sleep assessment tool such as the PSQI does 
not increase the identification of an insomnia diagnosis or increase the management of insomnia 
with medication in the rural primary care setting.   
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The results from this project support the role of advanced practice nursing by introducing 
data on the use of evidence-based sleep assessment tools in the rural primary care setting.  For 
providers seeking to optimize pain management strategies, the use of standardized sleep 
assessment tools such as the PSQI in primary care is valuable despite the nonsignificant findings 
from this project.  Results from this project do raise important questions about the role gender 
plays in the use of sleep medication, the undocumented use of sleep medication in the population 
of patients with chronic pain, and the unique barriers to addressing poor sleep quality in the 
primary care setting.  Future research is needed to inform care and improve this important 
dimension of chronic pain management in rural primary care settings. 
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• Supportive organizational culture 
• Strong dedication to community-
centered needs and care 
• Available and accessible workplace 
• Medical Director dedicated to 
minimizing the use of controlled 
substance pain medication whenever 
possible 
• Current EHR facilitates easy 
verification of chronic pain history 
Opportunities 
 
• Being the only healthcare facility in 
the immediate area attracts a broad 
population including those with 
chronic pain 
• No Pennsylvania-based pain 




• Inconsistency among staff rooming 
patients 
• Lack of consistent wireless internet 
access for electronic data collection 
• Multiple providers and support staff 
across two physical locations may 




• External environment accustomed to 
opioid use as the norm for chronic 
pain treatment 
• Difficulty in accessing external 
treatment records and history from 
other providers 














Records identified through 
database searching PubMed 
"Sleep"[MeSH] AND  “Pain 
Management “[MeSH] 
(n = 99) 
Additional records identified through  
database searching CINAHL and PsycINFO  
sleep quality or quality of sleep or sleep 
problem AND pain management or pain 
relief or pain control or pain reduction  
(n =703) 
Records after duplicates removed 
(n = 439) 
Records screened 
(n = 439) 
Records excluded if not in 
English (n = 62) 
Full-text articles 
assessed for eligibility 
(n = 377) 
Full-text articles excluded 
after title/abstract screen 
(n =269) 
Studies included  
in full-text review 
(n = 108) 
Studies included in 
literature review 
(n = 22) 
Full-text articles excluded 
due to irrelevant 
population or intervention 
(n = 86) 
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To evaluate the 









in the general 
population. 






Sleep deterioration has a 




There was insufficient 
evidence to suggest a 
clear positive effect of 
sleep improvement on 
pain.  
 
Poor sleep at baseline is a 
risk factor for developing 
a future pain condition. 
 
Changes in sleep are 
prospectively associated 
with the experience of 
pain, suggesting a 
potential causal 
association. 
Very small (3) number 
of studies included in 
the meta-analysis. 
 
Lack of uniformity in 
how the quality of 
sleep was assessed 
across the 16 studies 
reviewed. 
III B 
2 Alkkan Melikoglu, Eurasian 
Journal of Medicine, 2017 
Original 
correlational 
research study.  
 
To evaluate the 






70 patients with 
neuropathic pain 





in the study. No 
further description 
of the same 
Neuropathic pain 
duration, 
and pain intensity were 
factors related to 
having poor quality of 




Pittsburgh Sleep Quality 
scores, patients with 
The authors did not 
report the results of 
any power analysis or 
impact that a smaller 
sample size would 





number of females vs. 
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neuropathic pain had 
statistically significant 
lower quality of sleep 
latency, duration, 
efficiency, disturbance, 
and daytime dysfunction 
as compared to the 
control group. 
 
80% of patients with 
neuropathic pain and 
37% of controls were 
classified as having poor 
sleep quality. 
males represented in 
the recruited sample. 
 
No discussion of 
sample selection 
methods. 






whether a brief 
education session 
that incorporates 




help to improve 




sample of 85 
adults (18-80 





center in Alberta, 
Canada, who had 
experienced 
chronic pain for a 





assigned to either 
a control group or 




Disabled patients with 
diagnosed chronic pain 
and co-occurring 
disorders of anxiety, 
depression, and/or a 
diagnosed sleep disorder 
experienced measurable 
improvements in sleep 
latency following a brief 
one-on-one educational 
session about sleep 
hygiene. 
 
While sleep latency 
improved, other 




The study did not 
exclude participants on 
the basis of anxiety, 
depression, or other 
mental illness, any of 
which could have 
skewed results and are 
all highly present in 
this convenience 
sample of patients. 
 
It is unclear why 
additional patients 
were excluded from 
the study in the final 























4 Call-Schmidt, Pain 





The aim of the 
descriptive study 
was to determine 
the prevalence of 
sleep disturbance 
in adults with 





insomniac adults.  
 








sample of 99 
patients at an 
interdisciplinary 
pain clinic, which 




chronic pain.  
 
All patients in the 
study had chronic 
pain (>12 weeks, 
average length of 
time with pain = 
8.17 years).  
 
Patients with a 
history of CVA, 
cerebral 
neurological 
deficit, or history 






longer sleep latency, and 
decreased overall 
quality of sleep as 
compared to data from 
healthy patients without 
chronic pain. 
 
Sleep disturbance was 
positively correlated with 
the participants’ pain 
intensity scores as 
follows: r = .46 between 
pain intensity and Mid-
sleep awakening (MSA), 
r = .33 between pain 
intensity and Wake after 
sleep onset (WASO), r = 
0.35 between pain 
intensity and Movement 
during sleep (MDS), r = 
0.44 between pain 
intensity and Quality of 
disturbance (QD), r =.30 
between pain intensity 
and  
Sleep latency (SL), and r 
= 0.41 between pain 
intensity and Total sleep 
time (TST). 
 
Although 70% of 
participants were on 
Quality of sleep was 
based upon subjective 
reports from patients. 
 
Secondary data on 
“normal healthy” 
population used as a 
comparison is 
unidentified and 
unpublished, making it 
difficult to validate. 
 
Inadequate sample size 
to truly measure the 
effect of confounders 
such as gender and 
medication use in a 
generalizable way to 
the greater population. 
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opioid medication, sleep 
deprivation was still a 
problem. 
 
Sleep of men was more 
fragmented than that of 
women. 
 
The average sleep 
disturbance scores were 
consistently twice as high 
in the chronic pain 
population as compared 
with the healthy adult 
population with the 
exception of Wake After 
Sleep Onset.  
 
As the sample age 
increased, soundness of 
sleep increased. 












The sample was 
derived from the 
National Study of 
Daily Experiences 
(NSDE), a sub-
study within the 
Midlife in the 
United States 
Survey of 1031 
participants. A 
mean reported 
age of 47 years 




Individuals sleeping for 
less than 6 hours, or 
for 9 hours or more, 
reported more frequent 
pain complaints the 
following day. 
 
Sleeping for three hours 
or less was associated 
with an 81% increase in 
pain frequency relative to 
sleeping 6-9 hours. 
 
Sleep disturbance, 
manifested as either 
reduced or increased 
The assessment of 
sleep in this study was 
based solely on a 
single item question-
self reported total 
sleep time, which was 
subjective and only 
measured one 
dimension of sleep. 
 
Does not differentiate 
between acute and 
chronic pain. The 
questions asked on the 
telephone survey state, 
“daily pain” which 
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sleep duration, may serve 
as a marker identifying 
individuals at elevated 
risk for poor pain-related 
outcomes. 
may or may not be 
indicative of chronic 
pain. There is no data 
on the length of time 
patients have suffered 
from pain. 
6 Els, Cochrane Database of 
Systematic Reviews, 2017 
Systematic 









To provide an 
overview of the 
occurrence and 
nature of adverse 
events associated 
with opioid use in 
the treatment of 
chronic non 




61 unique studies 
with more than 
18,000 
participants 
related to opioid 
medications and 
their side effects. 
Opioids have the 
potential to alter sleep 
regulation, and are 
associated with poor 
sleep quality and 
insomnia. 
Serious harm event 
reporting in the 
articles reviewed was 
not performed 




Several of the studies 
included had a high 
attrition rate which 
raises questions about 
whether the results of 
those studies 
accurately captured the 
effect in the sample 
population that can be 
generalized to the 
general population. 
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Data support a reciprocal 
relationship between 
sleep disturbance and 
clinical pain reports. 
 
Insomnia symptoms 
significantly increase the 
risk of developing future 
chronic pain disorders in 
previously pain-free 
individuals. 
Lack of transparency 
in disclosing criteria 
for article inclusion 
and exclusion. Articles 
were chosen based 
upon relevance based 
upon the author’s own 























account for the 
associations 
between 
sleep and pain. 
Existing pain is not a 
strong predictor of new 
incident cases of 
insomnia. 
and mechanisms of the 
association of sleep 
and pain. 







aspects of pain in 
postmenopausal 







sample of 57 
postmenopausal 
women at the 
Universidade 
Federal de Sao 
Paulo’s women’s 
outpatient clinic 
were included in 
this study. 
The interference aspects 
of pain were statistically 
higher in the group of 
women with insomnia as 
compared to the control 
group without insomnia 




with insomnia perceive 
pain differently, 
independent of its 
intensity. 
Study does not 
consider and attempt 
to address 
comorbidities present 










To assess the role 






and seventeen age 










recruited for by 







twice as many days as 




During laboratory testing, 
primary insomnia 
subjects had lower pain 
thresholds than healthy 
controls. 
 
Pain-inhibitory circuits in 
patients with insomnia 
may be in a state of 
Possibility may exist 




Younger age of 
participants may not 
be generalizable to 




recruited based on 
his/her subjective 
perception of sleep 
habits which may 
differ from actual 
quality of sleep, 
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constant activation to 
compensate 
for ongoing subclinical 
pain which ultimately 
may result 
in a ceiling effect of the 
pain-inhibitory 
phenomenon. 
especially in the 
college-aged 
population which is 
known to have non-
standard sleep 
patterns. 





To examine the 
effect of sleep 
loss during part 



















Research Center.  
 
Participants were 
18 years of age 
and older must 
have been 
clinically stable 
on a DMARD for 
3 months or 




The purpose of 
the study was 
blinded to the 
participants 
Pain severity immediately 
after partial sleep 
deprivation was 
significantly greater than 
all other time points in 
patients with RA-related 
joint pain. 
 
Sleep loss activated 
RA-related joint pain as 
indicated by increases in 
the number of painful 
joints and the severity of 
associated joint pain. 
 
Partial sleep deprivation 
resulted in a slight 
increase in self-reported 
pain among health 
control subjects. 
The sample population 
was composed mainly 
of female subjects and 
as such may not be 
generalizable to male 
patients. 
 
Due to the limited 
power of the study, it 
cannot be possible to 
account for differences 
in baseline sleep 
quality and baseline 
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To summarize the 
available 





A total of seven 




the effects of 
sleep deprivation 
on pain 
The available evidence 
indicates that sleep 
deprivation does produce 




decreased after poor sleep 
interference and 
subsequently increased 
after recovery of REM 
sleep. 
 
Sleep deprivation is 
known to produce 
additional effects like 
sleepiness, increased 
fatigue, negative mood or 
cognitive dysfunctions, 
which might cause or 
mimic a modulation 
of pain processing. 
 
An ongoing cycle 
might arise starting either 
with disturbed sleep or 
with pain in which the 
two components stabilize 
or even augment each 
other to potentiate a pain 
response or sleep 
impairment. 
Several reviewed 
research articles were 
based upon animal 
trials which may not 
be transferrable to 
humans. 
 
The majority of 
studies reviewed on 
the relationship 
between sleep and 
pain were not based on 
an experimental 
design, but relied on 
correlation only. 
 
Four of the studies 
included in this review 
were comprised of 
mostly male 
participants or the 
sample population was 
entirely male which 
raises the question of 
the appropriateness of 
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sample of 90 
patients with knee 
osteoarthritis who 
came to the 
A significant positive 
relationship (r = 0.303; p 
= 0.004) was found 
between the sleep quality 
of patients with knee 
The presence of 
confounding factors as 
a yes/no choice limits 
the value in how they 
can be applied to pain, 
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To assess the 
quality of sleep 
and other factors 
affecting pain in 






of a hospital in 
Ordu, Turkey. 
osteoarthritis and pain 
scores. 
 
A significant negative 
relationship r = (-0. 387; 
p = 0.000) was found 
between the self-rated 
physical health and sleep 
quality scores. 
cold sensitivity, and 





hold more significance 
to the data. 
 
No discussion within 
the article of 
limitations. 













studies that used 
objective 
polysomnography 
in people with 
chronic pain. 















16 years or age 







subjective reports that 
individuals who suffer 
from chronic pain 
experience significant 
sleep disturbances. Of the 
sleep disturbance 
recorded both sleep 
initiation and 
maintenance was worse 
in patients with chronic 
pain. 
 
The pooled prevalence of 
sleep disorders in chronic 
pain was 44%, with 
insomnia, restless leg 
syndrome, and 
obstructive sleep apnea 
being the most common 
diagnoses. 
The prevalence studies 
included did not report 
the duration of the 
sleep disorders or 
when they were 
diagnosed in relation 
to the chronic pain 
making causal 
assumptions 
impossible to assume 
between sleep quality 
and the presence of 
chronic pain. 
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To investigate the 
role of disturbed 
sleep in the 
daily functioning 




chronic pain at a 
university pain 
clinic. The 
average age was 
46.7 years old. 










with greater pain (r = 
.26), disability (r = .49), 
depression (r = .41), 
physical symptoms (r = 
.34), and less daily 
uptime (r = -.27).  
 
Regression analyses 
showed that sleep 
disturbance predicted 
disability, daily uptime 
and physical symptoms 





were ineffective or 
unsatisfying 
potentially skewing 
the findings to 
demonstrate a stronger 
correlation between 
pain and sleep as 
compared to a sample 
more representative of 
the overall chronic 
pain population. This 
potentially weakens 
the study’s external 
validity and 
generalizability to the 
greater chronic pain 
patient population as a 
whole. 









sleep in a 
population of 
patients with 






chronic back pain: 
6 on non-opioid 
medication; 15 on 
opioid 
medication) ages 





Patients with chronic pain 
subjectively reported 
significant sleep and 
wake disturbances as 
shown by decreased 
overall sleep quality, 
increased symptoms of 
insomnia, and increased 
fatigue, increased time in 
bed, and taking longer to 
get to sleep as compared 
to healthy controls. 
 
Chronic pain can be 
The small sample 
size does not hold 
enough power to be 
generalizable to the 
general population. 
 
The age range 18-65 
may introduce a 
confounding factor, 
rate of metabolism and 
elimination of opioids, 
that was not addressed 
by this study. 
 
Actigraphy’s utility is 
limited as it cannot 
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to assess pain and 
sleep quality. 
associated with 
significant disruption in 
brain activity which is not 
improved by, and may 
even be exacerbated by 





sedation from opioid 
medication) and true 
sleep. 








sleep quality in 
patients with 
chronic low back 





quality of life. 
Two hundred 
patients (100 male 
and 100 female) 
admitted to an 







chronic low back 
pain were 
included in this 
study as well as 




The sleep quality of 
patients with chronic low 
back pain was worse 
compared to the healthy 
controls, and there was a 
positive relationship 
between the sleep quality 
with pain and functional 
status. Also, the poor 
sleep quality had negative 
effect on the physical 
component of quality of 
life. 
 
There was a statistically 
significant difference in 
quality of sleep between 
the genders. Women had 
decreased overall quality 
of sleep, worse sleep 
latency, sleep 
disturbance, increased 
use of sleep medications, 
and daytime dysfunction 
scores as compared to 
their male counterparts 
who also had chronic low 
back pain. 
Patients with a 
disclosed history of 
depression were 
excluded from the 
study potentially 
yielding incomplete 
results without this 
comorbid condition 
which frequently is 
cited as impacting 
sleep and pain 
perception. 
 
Quality of sleep was 
measured subjectively 
without actigraphy or 
polysomnography. 
 
The control group was 
comprised of friends, 
hospital staff, and 
relatives which, 
although convenient, 
may introduce bias 
into the study results. 
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To examine the 
potential benefits 
in relation to pain 
from trading time 
in one type of 









Activity and Sleep 
Monitoring Pilot 







Time spent performing 
moderate physical 
activity in lieu of sleep 
was associated with 
lower odds of pain in 
participants who did not 
report restless sleep. This 
relationship was not seen 
in participants who 
reported restless sleep 
activity.  
 
Sleep duration alone may 
not accurately reflect 
sleep quality. 
Restlessness may have a 
stronger relation to pain 
than sleep duration. 
Causation cannot be 
inferred from these 
observational data. 
 
The participants in the 
Osteoarthritis 
Initiative all reside in 
the northeast 
geographic region 
which may influence 
the type of moderate 
physical activity in 
which they chose to 
participate. Patients in 
other regions may not 
choose equivalent 
activities which may 
impact results.  
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18 Taylor-Gjevre, 




















arthritis and 78 
osteoarthritis 





practice over a 12‐




A high prevalence of 
abnormal sleep quality 
(63.7%) in both 
rheumatoid and 
osteoarthritis patient 
populations was observed 
despite reporting no 
known sleep disorder. 
 
The most common 
abnormality was sleep 




No significant differences 
between groups were 
observed in any of the 
sleep disturbance scores. 
Data for this study was 
entirely derived from 
self-administered 
questionnaires 
completed in the 
clinic. 
 
Due to the nature of 
the study being 
conducted over a 12-
month period, seasonal 
changes in the 
environment which 
have been known to 
effect the perceived 
severity of arthritis 
may have impacted 
patient pain and likely 
sleep perception at 
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Many arthritis patients 
will have sleep 
abnormalities without 
clear evidence of a 
primary sleep disorder. 
various points more 
than others. 




To evaluate the 
role that changes 
in sleep quality 
and fatigue might 
have on the 





sample of 125 
adult patients with 
chronic pain being 







in fatigue and sleep, were 
significantly 
associated with the 
reduction of pain 
intensity. 36% of 
participants reported 
significant improvements 
in pain intensity 
supporting sleep 
interventions, such as 
teaching sleep hygiene 
techniques or cognitive 
behavioral therapy for 
insomnia as potential 






Sleep and pain 
medication intake 
were not assessed 
making it possible that 
changes in these 
medications 
also had effects on 
sleep changes. 
 
As a correlational 
study, absolute 
causation cannot be 
determined even 
though it is 
longitudinal. 
 
The authors mention 
that patients may have 
been receiving 
multiple sleep related 
treatments at the same 
time however did not 
disclose or did not 
inquire as to what 
treatments these were. 
It is difficult to know 
which sleep related 
intervention is 
responsible for 
































patterns of people 
with chronic low 
back pain, and 
compare this to 
age- and gender 
matched controls. 
A convenience 
sample of 16 
people with 
chronic low back 
pain was recruited 
from the waiting 









without report of 
low back pain 
were recruited by 




College of Dublin 
The chronic low back 
pain group had 
significantly higher 
scores on both subjective 
sleep quality instruments 
(PSQI and ISI) when 
compared to the control 
group. 
 
The chronic low back 
pain group had 
significantly longer sleep 
onset latency as 
compared to the control 
group without any 
difference in actigraphy 
data to indicate a change 
in sleep pattern. 
 
There was a significant 
negative correlation 
between the PSQI total 
sleep time and Oswestry 
Disability Index disability 
score (r = -0.628; p =  
0.021). 
Attrition in this study 




keeping sleep diaries. 
This lowered the 
power of this study. 
 
The chronic low back 
pain group had a 
higher BMI than the 
control group 
potentially 
predisposing them to 
greater sleep 
impairment and OSA. 
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purpose of this 





Data collected on 
6277 adults who 
took part in, “The 
new workplace: 
Work, health, and 
participation in 
the new work life” 
study conducted 
by the Norwegian 
National Institute 
The psychosocial 
dimension “coworker  
support” showed a 
significant relationship (p 
= 0.028), with the number 
of musculoskeletal pain 
sites. There was a 
positive association with 
“coworker support” and 
sleep initiation but no 
While the study used 
evidence supported 
survey questions for 
measuring 
psychosocial work 
factors, only two 
questions related to 
sleep quality and 
initiation were asked 
of participants to 
assess sleep. The use 
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The subset of 
adults from the 
original study was 






association with sleep 
disturbance. 
 
Sleep may be a mediating 
factor in the relationship 
between pain and work-
related psychosocial 
stressors. 
of a full sleep 
assessment tool would 
have strengthened the 
inference of sleep as a 




The survey instrument 
made it impossible to 
investigate reverse 
causality effects of 
sleep and pain on each 
workers’ self-reported 
work environment. 
22 Wong, Journal of 







of chronic pain, 
insomnia, and 
fatigue in terms 
of prevalence and 
associated factors 
in the general 
adult population 
of Hong Kong. 
5001 adults aged 
≥18 years drawn 







survey over the 
phone. 
The observed 
prevalence of reporting 
all three chronic 
symptoms (pain, fatigue, 
insomnia) was 6%. 
 
Women had a higher 





were the most prevalent 
comorbidity at 15%. 
The response rate to 
the telephone surveys 
was 58%, potentially 
excluding the 
representation of a 





The working male 
population was less 
likely to be available 
to answer the phone 
during the interview 
calls leading to 
underrepresentation of 
this demographic in 
the study results. 
III B 
* From: Dang, D., & Dearholt, S. L. (2018). Johns Hopkins evidence-based practice: Model and guidelines (3rd ed.). Indianapolis, 
IN: Sigma Theta Tau.   
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Appendix D: 





















Informed Consent/Information Script 
Informed Consent Form 
Messiah College 
 
Title of Project: Screening for Sleep Quality in Patients Presenting to a Primary  
Care Office with Chronic Pain: A Quality Improvement Project 
 
Principal Investigator: Nicholas Montgomery, BSN, RN 
949 Cedar Hollow Rd. 
Hollidaysburg, PA 16648 
nm1278@messiah.edu 
814.571.0982   
 
Advisor:    Kristen L. Slabaugh, DNP, CRNP, FNP-C, CNE 
Associate Professor of Nursing, Clinical Track 
Coordinator of DNP/FNP Program 
Messiah College 
One College Ave, Suite 3031 




1. Purpose of the Study: The purpose of this research is to give patients who experience chronic  
pain the opportunity to take a brief (5-10 minute) survey about sleep. The results will be shared  
with your provider and may suggest that you have “good” or “poor” sleep quality. You or your 
provider may then have the opportunity to discuss your results during your visit. 
 
2. Procedures to be followed: You will be asked to complete a brief 10-question sleep survey  
asking questions about your sleep habits. Staff will collect the completed sleep survey, tally the 
results, and share them with your provider. You and your provider may then discuss the results  
and he/she may make specific recommendations to you based on his/her opinion and established 
professional guidelines. 
 
3. Discomforts and Risks: There are no risks in participating in this research beyond those 
experienced in everyday life. Some of the questions are personal and might cause discomfort. 
 
4. Benefits: The benefits to you include being afforded an opportunity to discuss your sleep habits  
with your provider and may reveal new recommendations to improve your sleep quality and  
quality of life. 
 
The benefits to society include indirect cost savings as a result of improved care resulting in 
decreased utilization of healthcare resources and increases in productivity on a population-wide 
basis.  
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5. Duration/Time: The initial time to complete the sleep survey is expected to take 5-10 minutes  
of your time. Any results from the sleep survey that you discuss with your provider at this and  
future appointments is in addition to that time. 
 
6. Statement of Confidentiality: Your participation in this research is confidential. The data will  
be stored and secured at Hyndman Area Health Center in a locked and password-protected file. 
Messiah College’s Institutional Review Board for the Protection of Human Subjects, and the 
Department of Health and Human Services’ Office for Human Research Protections may review 
records related to this research study. In the event of a publication or presentation resulting from  
the research, no personally identifiable information will be shared. 
 
7. Right to Ask Questions: Please contact the principal researcher, Nicholas Montgomery at 
814.571.0982, or the research advisor, Kristen Slabaugh at 717.796.1800 x6560, with questions, 
complaints, or concerns about this research. You can also call this number if you feel this study  
has harmed you. Questions about your rights as a research participant may be directed to Messiah 
College’s Office of the Provost at 717.766.2511 x5375. You may also call this number if you  
cannot reach the research team or wish to talk to someone else. 
 
8. Voluntary Participation: Your decision to be in this research is voluntary. You can stop at any 
time. You do not have to answer any questions you do not want to answer. Refusal to take part in  
or withdrawing from this study will involve no penalty or loss of benefits you would receive 
otherwise. 
 
You must be 18 years of age or older to consent to take part in this research study. If you agree to take 
part in this research study and the information outlined above, please sign your name and indicate the 
date below.  
 





_____________________________________________  _____________________ 
Participant Signature       Date 
 
 
The informed consent procedure has been followed. 
 
_____________________________________________  _____________________ 
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Appendix H 
Permission for Use of PSQI 
 
 




Educational Handout for Provider Distribution to Patients 
 












If no chronic pain, no 
intervention indicated 
If yes to chronic pain, 
supply patient with 
consent to participate 
and PSQI survey 
If appropriate, assess 
sleep quality further 
and provide treatment 
recommendations 
If patient scores 5 or 
less on PSQI, no 
further action required 
If patient scores > 5 
on PSQI, alert 
provider to score 
Provider conducts 
further investigation 
and management as 
indicated 
If inappropriate or not 
in patient’s best 
interest, no further 
action needed. 
With support from project manager 
 











Practitioners 472.00/month 1416.00* 
Support Staff 63.00/month 189.00* 
Project Manager 2475.00/month 7425.00* 





Copies 25.00/month 75.00* 
Provider Handouts 60.00 60.00* 
Total Startup Costs 135.00* 
Capital Costs 
Physical Supplies 5.00/month 15.00* 





Electricity/Utilities 0.00/month 0.00 
Physical Workspace 0.00/month 0.00 
Total Operational Costs 0.00 
Total Project Expenses 9180.00 
Project Revenue 
Revenue Generation  0.00 
Total Project Revenue 0.00 
Project Benefit/Loss 
Total Revenue 0.00 
Less Expenses 9180.00 
Total Program Benefit/Loss -9180.00* 
*Donated by DNP student and/or implementation facility 





0 50 100 150 200 250 300 350 400 450
Write Proposal
Present Proposal
Obtain Implementation Site Final Approval
Obtain IRB Approval
Prepare Materials
First Staff Meeting: Introduce Project
Second Staff Meeting: Address Questions
Begin Project with Project Manager Direct Support
Project Continues with Indirect Support
Data Compilation
Statistical Analysis
Share results with Implementation Site
Write Manuscript
Submit Final Manuscript
Days of the Project
 














        
 
Write Proposal 7/15 7/30 0 16  
Present Proposal 8/5 8/5 21 1  
Obtain Implementation Site Final 
Approval 9/1 1/24 48 146  
Obtain IRB Approval 1/24 2/24 193 32  
Prepare Materials 12/1 12/31 139 31 
Implementation          
First Staff Meeting: Introduce 
Project 3/1 3/7 230 7  
Second Staff Meeting: Address 
Questions 3/8 3/15 237 8  
Begin Project with Project 
Manager Direct Support 3/16 3/22 245 7  
Project Continues with Indirect 
Support 3/23 5/16 252 55 
Post-Implementation          
Data Compilation 5/17 5/31 307 15  
Statistical Analysis 6/1 6/19 322 19  
Share results with Implementation 
Site 6/20 6/26 341 7  
Write Manuscript 6/1 7/31 322 61  
Submit Final Manuscript 8/1 8/7 383 7 
 






Myocardial Infarction 11.10% (n = 1) 
Coronary Heart Disease 66.70% (n = 6) 
Stroke 0% (n = 0) 
Asthma 22.20% (n = 2) 
Chronic Obstructive Pulmonary Disease 44.40% (n = 4) 
Arthritis 44.40% (n = 4) 
Depression 55.60% (n = 5) 
Diabetes 33.30% (n = 3) 
Obesity 88.90% (n = 8) 
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Appendix N 
Summary of PSQI Scores by Sleep Dimension 
 
 
Sleep Dimension Possible Score Mean (SD) 
Subjective Sleep Quality 0-3 2.22 (.83) 
Sleep Latency 0-3 2.11 (1.05) 
Sleep Duration 0-3 1.89 (1.45) 
Sleep Efficiency 0-3 1.78 (1.48) 
Sleep Disturbance 0-3 2.11 (.33) 
Sleep Medication 0-3 1.33 (1.58) 
Daytime Disturbance 0-3 1.56 (1.01) 
Global PSQI Score 0-21 13.00 (5.24) 
 
